Interní Med. 2019; 21(2): 76-82 | DOI: 10.36290/int.2019.040

Current approach to diagnosing and treating allergic rhinitis

MUDr. Jiří Nevrlka
UPIRA, s. r. o. (Úspěšná péče o imunitu, respiraci a alergie), Brno

Viewing rhinitis through the prism of an uncomplicated transient cold or mild vasomotor disorder may lead to a general underestimation of this diagnosis. Even in society-wide terms, it is necessary to underscore the objective significance of this condition, particularly that of chronic and allergic rhinitis. The aim of the article is to present a fundamental review of the issue of allergic rhinitis, ranging from its characteristics to classification and significance to therapeutic intervention. It also explains the role of an allergist in the system of care for patients affected by allergic rhinitis as well as deals in more detail with the options of lifestyle measures and general treatment. This article is a follow-up to previous review papers in this journal.

Keywords: chronic rhinitis, allergic rhinitis, ARIA, allergic rhinitis treatment, H1-antihistamines, nasal corticosteroids, allergen--specific immunotherapy

Accepted: February 6, 2019; Published: May 10, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevrlka J. Current approach to diagnosing and treating allergic rhinitis. Interní Med. 2019;21(2):76-82. doi: 10.36290/int.2019.040.
Download citation

References

  1. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group., World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001 Nov. 108 (5 Suppl): S147-334. Go to original source... Go to PubMed...
  2. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group., World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001 Nov. 108 (5 Suppl): S147-334. Go to original source... Go to PubMed...
  3. Seberová E. Doporučení alergická rýma. Česká společnost alergologie a klinické imunologie. [online]. Dostupné na www.csaki.cz
  4. Krčmová I, Novosad J. Moderní aspekty alergické rýmy. Interní med. 2018; 20(2): 74-80. Go to original source...
  5. Seberová E. Alergická rýma, 2.vydání. Praha: Maxdorf 2017: 119 s.
  6. Rondón C, et al. Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis. J Allergy Clin Immunol 2011 Dec. 128(6): 1192-7. Go to original source... Go to PubMed...
  7. Cirillo I, Marseglia G, Klersy C et al. Allergic patients have more numerous and prolonged respiratory infections than non allergic subjects. Allergy 2007; 62: 1087-1090. Go to original source... Go to PubMed...
  8. Lamb CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr. Med. Res. Opin., 2006; 22(6): 1203-1210. Go to original source... Go to PubMed...
  9. Brozek JL, Bousquet J, Agache IO, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol, 140(4), 950-958. Go to original source... Go to PubMed...
  10. A?t-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009 Jan. 64 (1): 123-148. Go to original source... Go to PubMed...
  11. Fokkens W, Lund V, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007; 45: (Suppl 20):1-136. Go to PubMed...
  12. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology Suppl. 2012;(23):1-298.
  13. Kastner J. EP3OS - Evropský konsensus o rinosinusitidě a nosní polypóze 2012 (kapesní průvodce), Praha: GlaxoSmithKline 2012: 24 s.
  14. Alergická rýma a její vliv na astma. Kapesní průvodce pro lékaře a zdravotní sestry, Praha: ČIPA 2010.
  15. Petrů V. Novinky v alergenové imunoterapii. Interní med. 2017; 19(2): 78-81. Go to original source...
  16. Rybníček O, Seberová E, et al. Průvodce specifickou alergenovou imunoterapií (SIT), Doporučení ČSAKI 2009, edit. ČIPA, o. p. s., vyd. Tigis.
  17. Nevrlka J, "Domácí" inhalační alergie - povaha, léčba a prevence. Zdravotnické noviny 2012; 61, 14:4.
  18. Simons FE. H1-receptor antagonists: clinical pharmacology and therapeutics. J Allergy Clin Immunol. 1989 Dec; 84(6 Pt 1): 845-61. Go to original source... Go to PubMed...
  19. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids, new developments. Am J Respir Crit Care Med 1998; 157: S1-S53. Go to original source... Go to PubMed...
  20. Bielory L et al. Position statement. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the AAAAI and the ACAAI. J Alergy Clin Immunol 2006; 96: 514-524. Go to original source...
  21. Fokkens WJ. Nasal corticosteroids, first choice in moderate to severe allergic rhinitis. What prevents general practitioners from using them? Allergy 2003; 58: 724-726. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.